{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T02:07:22Z","timestamp":1789524442358,"version":"build-2803163510"},"reference-count":173,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T00:00:00Z","timestamp":1682985600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.esmoop.2023.101573","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T11:34:42Z","timestamp":1685532882000},"page":"101573","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["MiRNA dysregulation underlying common pathways in type 2 diabetes and cancer development: an Italian Association of Medical Oncology (AIOM)\/Italian Association of Medical Diabetologists (AMD)\/Italian Society of Diabetology (SID)\/Italian Society of Endocrinology (SIE)\/Italian Society of Pharmacology (SIF) multidisciplinary critical view"],"prefix":"10.1016","volume":"8","author":[{"given":"A.","family":"Natalicchio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Montagnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Marrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Faggiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.C.","family":"Zatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Mazzilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Argentiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Danesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"D\u2019Oronzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Fogli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Giuffrida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Gori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ragni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Renzelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Franchina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Tuveri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Sciacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Monami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Cirino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Di Cianni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Colao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Avogaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Cinieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Silvestris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Giorgino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.esmoop.2023.101573_bib1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","article-title":"IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045","volume":"138","author":"Cho","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.esmoop.2023.101573_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"issue":"7","key":"10.1016\/j.esmoop.2023.101573_bib4","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/dme.13919","article-title":"Challenges in the management of people with diabetes and cancer","volume":"36","author":"Chowdhury","year":"2019","journal-title":"Diabet Med"},{"issue":"4","key":"10.1016\/j.esmoop.2023.101573_bib5","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4103\/apjon.apjon_40_17","article-title":"Importance of glycemic control in cancer patients with diabetes: treatment through end of life","volume":"4","author":"Hershey","year":"2017","journal-title":"Asia Pac J Oncol Nurs"},{"key":"10.1016\/j.esmoop.2023.101573_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103572","volume":"169","author":"Natalicchio","year":"2022","journal-title":"Crit Rev Oncol Hematol"},{"issue":"8","key":"10.1016\/j.esmoop.2023.101573_bib7","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1001\/jamaoncol.2018.1684","article-title":"Incidence of diabetes after cancer development: a Korean national cohort study","volume":"4","author":"Hwangbo","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.esmoop.2023.101573_bib8","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.2337\/dc10-0666","article-title":"Diabetes and cancer: a consensus report","volume":"33","author":"Giovannucci","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.esmoop.2023.101573_bib9","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.diabres.2018.04.002","article-title":"Diabetes and cancer: pathophysiological fundamentals of a \u2018dangerous affair.\u2019","volume":"143","author":"Cignarelli","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"10.1016\/j.esmoop.2023.101573_bib10","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1672-0229(08)60044-3","article-title":"A\u00a0brief review on the mechanisms of miRNA regulation","volume":"7","author":"Cai","year":"2009","journal-title":"Genomics Proteomics Bioinformatics"},{"issue":"12","key":"10.1016\/j.esmoop.2023.101573_bib11","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.3390\/cells8121533","article-title":"MicroRNA signatures as future biomarkers for diagnosis of diabetes states","volume":"8","author":"Vasu","year":"2019","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.esmoop.2023.101573_bib12","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1373\/clinchem.2010.147405","article-title":"The microRNA spectrum in 12 body fluids","volume":"56","author":"Weber","year":"2010","journal-title":"Clin Chem"},{"issue":"3","key":"10.1016\/j.esmoop.2023.101573_bib13","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd.2016.246","article-title":"MicroRNA therapeutics: towards a new era for the management of cancer and other diseases","volume":"16","author":"Rupaimoole","year":"2017","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"10.1016\/j.esmoop.2023.101573_bib14","doi-asserted-by":"crossref","first-page":"e468","DOI":"10.1002\/ctm2.468","article-title":"Emerging roles of exosomal miRNAs in diabetes mellitus","volume":"11","author":"He","year":"2021","journal-title":"Clin Transl Med"},{"issue":"2","key":"10.1016\/j.esmoop.2023.101573_bib15","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/apha.12681","article-title":"MicroRNAs in metabolism","volume":"219","author":"Vienberg","year":"2017","journal-title":"Acta Physiol (Oxf)"},{"issue":"2","key":"10.1016\/j.esmoop.2023.101573_bib16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/14728222.2018.1420168","article-title":"MicroRNAs as therapeutic targets for the treatment of diabetes mellitus and its complications","volume":"22","author":"Regazzi","year":"2018","journal-title":"Expert Opin Ther Targets"},{"issue":"7014","key":"10.1016\/j.esmoop.2023.101573_bib17","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature03076","article-title":"A\u00a0pancreatic islet-specific microRNA regulates insulin secretion","volume":"432","author":"Poy","year":"2004","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.esmoop.2023.101573_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055272","article-title":"The miRNA profile of human pancreatic islets and beta-cells and relationship to type 2 diabetes pathogenesis","volume":"8","author":"van de Bunt","year":"2013","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.esmoop.2023.101573_bib19","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.2337\/db07-0175","article-title":"MicroRNA expression is required for pancreatic islet cell genesis in the mouse","volume":"56","author":"Lynn","year":"2007","journal-title":"Diabetes"},{"issue":"14","key":"10.1016\/j.esmoop.2023.101573_bib20","doi-asserted-by":"crossref","first-page":"5813","DOI":"10.1073\/pnas.0810550106","article-title":"miR-375 maintains normal pancreatic alpha- and beta-cell mass","volume":"106","author":"Poy","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.esmoop.2023.101573_bib21","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/apha.12460","article-title":"Modulation of microRNA-375 expression alters voltage-gated Na(+) channel properties and exocytosis in insulin-secreting cells","volume":"213","author":"Salunkhe","year":"2015","journal-title":"Acta Physiol (Oxf)"},{"issue":"27","key":"10.1016\/j.esmoop.2023.101573_bib22","doi-asserted-by":"crossref","first-page":"10438","DOI":"10.1074\/jbc.RA119.007755","article-title":"MicroRNA-223 is essential for maintaining functional \u03b2-cell mass during diabetes through inhibiting both FOXO1 and SOX6 pathways","volume":"294","author":"Li","year":"2019","journal-title":"J\u00a0Biol Chem"},{"issue":"3","key":"10.1016\/j.esmoop.2023.101573_bib23","doi-asserted-by":"crossref","first-page":"394","DOI":"10.2337\/db21-0134","article-title":"Obesity-induced miR-455 upregulation promotes adaptive pancreatic \u03b2-cell proliferation through the CPEB1\/CDKN1B pathway","volume":"71","author":"Hu","year":"2022","journal-title":"Diabetes"},{"key":"10.1016\/j.esmoop.2023.101573_bib24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fendo.2020.00009","article-title":"MicroRNA-17-92 regulates beta-cell restoration after streptozotocin treatment","volume":"11","author":"Wan","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"11","key":"10.1016\/j.esmoop.2023.101573_bib25","article-title":"Deletion of pancreas-specific miR-216a reduces beta-cell mass and inhibits pancreatic cancer progression in mice","volume":"2","author":"Erener","year":"2021","journal-title":"Cell Rep Med"},{"issue":"10","key":"10.1016\/j.esmoop.2023.101573_bib26","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.2337\/db07-1252","article-title":"Alterations in microRNA expression contribute to fatty acid-induced pancreatic beta-cell dysfunction","volume":"57","author":"Lovis","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.esmoop.2023.101573_bib27","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s12020-022-03016-9","article-title":"miR-25 and miR-92b regulate insulin biosynthesis and pancreatic \u03b2-cell apoptosis","volume":"76","author":"Shen","year":"2022","journal-title":"Endocrine"},{"key":"10.1016\/j.esmoop.2023.101573_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154335","article-title":"Inhibition of miR-153, an IL-1\u03b2-responsive miRNA, prevents beta cell failure and inflammation-associated diabetes","volume":"111","author":"Sun","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.esmoop.2023.101573_bib29","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.omtn.2021.08.027","article-title":"miR-320a induces pancreatic \u03b2 cells dysfunction in diabetes by inhibiting MafF","volume":"26","author":"Du","year":"2021","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.esmoop.2023.101573_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118571","article-title":"miR-383 ameliorates high glucose-induced \u03b2-cells apoptosis and hyperglycemia in high-fat induced diabetic mice","volume":"263","author":"Cheng","year":"2020","journal-title":"Life Sci"},{"issue":"11","key":"10.1016\/j.esmoop.2023.101573_bib31","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.2337\/db18-0223","article-title":"Glucolipotoxicity-inhibited miR-299-5p regulates pancreatic \u03b2-cell function and survival","volume":"67","author":"Huang","year":"2018","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.esmoop.2023.101573_bib32","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1261\/rna.1211209","article-title":"Identification of glucose-regulated miRNAs from pancreatic {beta} cells reveals a role for miR-30d in insulin transcription","volume":"15","author":"Tang","year":"2009","journal-title":"RNA"},{"issue":"5","key":"10.1016\/j.esmoop.2023.101573_bib33","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/wrna.1240","article-title":"Influence of miRNA in insulin signaling pathway and insulin resistance: micro-molecules with a major role in type-2 diabetes","volume":"5","author":"Chakraborty","year":"2014","journal-title":"Wiley Interdiscip Rev RNA"},{"issue":"6","key":"10.1016\/j.esmoop.2023.101573_bib34","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1172\/JCI73066","article-title":"MicroRNA-7a regulates pancreatic \u03b2 cell function","volume":"124","author":"Latreille","year":"2014","journal-title":"J\u00a0Clin Invest"},{"issue":"6","key":"10.1016\/j.esmoop.2023.101573_bib35","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/nm.3862","article-title":"The microRNA-200 family regulates pancreatic beta cell survival in type 2 diabetes","volume":"21","author":"Belgardt","year":"2015","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.esmoop.2023.101573_bib36","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.jmb.2019.09.017","article-title":"Micro(RNA) management and mismanagement of the islet","volume":"432","author":"Eliasson","year":"2020","journal-title":"J\u00a0Mol Biol"},{"issue":"37","key":"10.1016\/j.esmoop.2023.101573_bib37","doi-asserted-by":"crossref","first-page":"26932","DOI":"10.1074\/jbc.M601225200","article-title":"MicroRNA-9 controls the expression of granuphilin\/Slp4 and the secretory response of insulin-producing cells","volume":"281","author":"Plaisance","year":"2006","journal-title":"J\u00a0Biol Chem"},{"issue":"3","key":"10.1016\/j.esmoop.2023.101573_bib38","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1515\/BC.2008.026","article-title":"Regulation of the expression of components of the exocytotic machinery of insulin-secreting cells by microRNAs","volume":"389","author":"Lovis","year":"2008","journal-title":"Biol Chem"},{"issue":"5","key":"10.1016\/j.esmoop.2023.101573_bib39","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/emboj.2010.361","article-title":"miRNAs control insulin content in pancreatic \u03b2-cells via downregulation of transcriptional repressors","volume":"30","author":"Melkman-Zehavi","year":"2011","journal-title":"EMBO J"},{"issue":"4","key":"10.1016\/j.esmoop.2023.101573_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018613","article-title":"Differential glucose-regulation of microRNAs in pancreatic islets of non-obese type 2 diabetes model Goto-Kakizaki rat","volume":"6","author":"Esguerra","year":"2011","journal-title":"PLoS One"},{"issue":"21","key":"10.1016\/j.esmoop.2023.101573_bib41","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.13493","article-title":"MiR-335 overexpression impairs insulin secretion through defective priming of insulin vesicles","volume":"5","author":"Salunkhe","year":"2017","journal-title":"Physiol Rep"},{"issue":"1","key":"10.1016\/j.esmoop.2023.101573_bib42","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s00125-013-3089-4","article-title":"Increased expression of miR-187 in human islets from individuals with type 2 diabetes is associated with reduced glucose-stimulated insulin secretion","volume":"57","author":"Locke","year":"2014","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.esmoop.2023.101573_bib43","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00592-014-0675-y","article-title":"MicroRNA-124a is hyperexpressed in type 2 diabetic human pancreatic islets and negatively regulates insulin secretion","volume":"52","author":"Sebastiani","year":"2015","journal-title":"Acta Diabetol"},{"issue":"1","key":"10.1016\/j.esmoop.2023.101573_bib44","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3892\/etm.2021.10096","article-title":"miRNA-770-5p expression is upregulated in patients with type 2 diabetes and miRNA-770-5p knockdown protects pancreatic \u03b2-cell function via targeting BAG5 expression","volume":"22","author":"Wang","year":"2021","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.esmoop.2023.101573_bib45","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/5219782","article-title":"miR-29a negatively affects glucose-stimulated insulin secretion and MIN6 cell proliferation via Cdc42\/\u03b2-catenin signaling","volume":"2019","author":"Duan","year":"2019","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.esmoop.2023.101573_bib46","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.lfs.2019.01.031","article-title":"MicroRNA-125b-5p improves pancreatic \u03b2-cell function through inhibiting JNK signaling pathway by targeting DACT1 in mice with type 2 diabetes mellitus","volume":"224","author":"Yu","year":"2019","journal-title":"Life Sci"},{"issue":"9","key":"10.1016\/j.esmoop.2023.101573_bib47","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/nm.3287","article-title":"Thioredoxin-interacting protein regulates insulin transcription through microRNA-204","volume":"19","author":"Xu","year":"2013","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.esmoop.2023.101573_bib48","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1007\/s00125-013-2993-y","article-title":"Identification of particular groups of microRNAs that positively or negatively impact on beta cell function in obese models of type 2 diabetes","volume":"56","author":"Nesca","year":"2013","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.esmoop.2023.101573_bib49","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.3390\/cells9071621","article-title":"miR-7 regulates GLP-1-mediated insulin release by targeting \u03b2-arrestin 1","volume":"9","author":"Matarese","year":"2020","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.esmoop.2023.101573_bib50","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1210\/me.2014-1335","article-title":"Induction of miR-132 and miR-212 expression by glucagon-like peptide 1 (GLP-1) in rodent and human pancreatic \u03b2-cells","volume":"29","author":"Shang","year":"2015","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.esmoop.2023.101573_bib51","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.molmet.2019.11.012","article-title":"MiR-132 controls pancreatic beta cell proliferation and survival through Pten\/Akt\/Foxo3 signaling","volume":"31","author":"Mziaut","year":"2020","journal-title":"Mol Metab"},{"issue":"8","key":"10.1016\/j.esmoop.2023.101573_bib52","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1210\/me.2016-1056","article-title":"miR-204 targets PERK and regulates UPR signaling and \u03b2-cell apoptosis","volume":"30","author":"Xu","year":"2016","journal-title":"Mol Endocrinol"},{"issue":"4","key":"10.1016\/j.esmoop.2023.101573_bib53","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/ncb2211","article-title":"Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism","volume":"13","author":"Jordan","year":"2011","journal-title":"Nat Cell Biol"},{"issue":"7","key":"10.1016\/j.esmoop.2023.101573_bib54","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1007\/s00125-012-2539-8","article-title":"Downregulation of miR-181a upregulates sirtuin-1 (SIRT1) and improves hepatic insulin sensitivity","volume":"55","author":"Zhou","year":"2012","journal-title":"Diabetologia"},{"issue":"7353","key":"10.1016\/j.esmoop.2023.101573_bib55","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nature10112","article-title":"MicroRNAs 103 and 107 regulate insulin sensitivity","volume":"474","author":"Trajkovski","year":"2011","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.esmoop.2023.101573_bib56","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ymgme.2007.03.011","article-title":"Energizing miRNA research: a review of the role of miRNAs in lipid metabolism, with a prediction that miR-103\/107 regulates human metabolic pathways","volume":"91","author":"Wilfred","year":"2007","journal-title":"Mol Genet Metab"},{"issue":"7435","key":"10.1016\/j.esmoop.2023.101573_bib57","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature11793","article-title":"Obesity-induced overexpression of miR-802 impairs glucose metabolism through silencing of Hnf1b","volume":"494","author":"Kornfeld","year":"2013","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.esmoop.2023.101573_bib58","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1111\/j.1440-1681.2009.05207.x","article-title":"Changes in microRNA (miR) profile and effects of miR-320 in insulin-resistant 3T3-L1 adipocytes","volume":"36","author":"Ling","year":"2009","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"2","key":"10.1016\/j.esmoop.2023.101573_bib59","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s12032-013-0557-0","article-title":"Downregulation of miR-383 promotes glioma cell invasion by targeting insulin-like growth factor 1 receptor","volume":"30","author":"He","year":"2013","journal-title":"Med Oncol"},{"issue":"Pt 12","key":"10.1016\/j.esmoop.2023.101573_bib60","first-page":"2678","article-title":"Regulation of IRS1\/Akt insulin signaling by microRNA-128a during myogenesis","volume":"126","author":"Motohashi","year":"2013","journal-title":"J\u00a0Cell Sci"},{"issue":"7","key":"10.1016\/j.esmoop.2023.101573_bib61","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.cell.2007.04.040","article-title":"A\u00a0mammalian microRNA expression atlas based on small RNA library sequencing","volume":"129","author":"Landgraf","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.esmoop.2023.101573_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102912","article-title":"Obesity-related hypoxia via miR-128 decreases insulin-receptor expression in human and mouse adipose tissue promoting systemic insulin resistance","volume":"59","author":"Arcidiacono","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.esmoop.2023.101573_bib63","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.54298","article-title":"Targeting mir128-3p alleviates myocardial insulin resistance and prevents ischemia-induced heart failure","volume":"9","author":"Ruiz-Velasco","year":"2020","journal-title":"Elife"},{"issue":"3","key":"10.1016\/j.esmoop.2023.101573_bib64","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.bbrc.2013.03.104","article-title":"The induction of miR-96 by mitochondrial dysfunction causes impaired glycogen synthesis through translational repression of IRS-1 in SK-Hep1 cells","volume":"434","author":"Jeong","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.esmoop.2023.101573_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017343","article-title":"The induction of microRNA targeting IRS-1 is involved in the development of insulin resistance under conditions of mitochondrial dysfunction in hepatocytes","volume":"6","author":"Ryu","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.esmoop.2023.101573_bib66","first-page":"353","article-title":"Development of insulin resistance through induction of miRNA-135 in C2C12 cells","volume":"18","author":"Honardoost","year":"2016","journal-title":"Cell J"},{"issue":"1","key":"10.1016\/j.esmoop.2023.101573_bib67","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nsmb.1533","article-title":"miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42","volume":"16","author":"Park","year":"2009","journal-title":"Nat Struct Mol Biol"},{"issue":"11","key":"10.1016\/j.esmoop.2023.101573_bib68","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/gcc.20596","article-title":"The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers","volume":"47","author":"Guo","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"issue":"3","key":"10.1016\/j.esmoop.2023.101573_bib69","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s10495-013-0802-1","article-title":"MicroRNA-384-5p regulates ischemia-induced cardioprotection by targeting phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta (PI3K p110\u03b4)","volume":"18","author":"Bao","year":"2013","journal-title":"Apoptosis"},{"issue":"1","key":"10.1016\/j.esmoop.2023.101573_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules18010001","article-title":"The feedback regulation of PI3K-miR-19a, and MAPK-miR-23b\/27b in endothelial cells under shear stress","volume":"18","author":"He","year":"2012","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.esmoop.2023.101573_bib71","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.bbrc.2008.09.050","article-title":"Up-regulated expression of microRNA-143 in association with obesity in adipose tissue of mice fed high-fat diet","volume":"376","author":"Takanabe","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"10.1016\/j.esmoop.2023.101573_bib72","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1210\/me.2007-0167","article-title":"Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes","volume":"21","author":"He","year":"2007","journal-title":"Mol Endocrinol"},{"issue":"22","key":"10.1016\/j.esmoop.2023.101573_bib73","doi-asserted-by":"crossref","first-page":"9232","DOI":"10.1073\/pnas.1102281108","article-title":"miR-33a\/b contribute to the regulation of fatty acid metabolism and insulin signaling","volume":"108","author":"D\u00e1valos","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.esmoop.2023.101573_bib74","doi-asserted-by":"crossref","first-page":"123","DOI":"10.14348\/molcells.2017.2228","article-title":"IRS-2 partially compensates for the insulin signal defects in IRS-1-\/- mice mediated by miR-33","volume":"40","author":"Tang","year":"2017","journal-title":"Mol Cells"},{"key":"10.1016\/j.esmoop.2023.101573_bib75","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.molmet.2018.08.003","article-title":"MicroRNA-205-5p is a modulator of insulin sensitivity that inhibits FOXO function","volume":"17","author":"Langlet","year":"2018","journal-title":"Mol Metab"},{"issue":"6","key":"10.1016\/j.esmoop.2023.101573_bib76","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1159\/000475912","article-title":"Mir-338-3p mediates Tnf-A-induced hepatic insulin resistance by targeting PP4r1 to regulate PP4 expression","volume":"41","author":"Dou","year":"2017","journal-title":"Cell Physiol Biochem"},{"issue":"6","key":"10.1016\/j.esmoop.2023.101573_bib77","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1159\/000430198","article-title":"MiR-499-5p contributes to hepatic insulin resistance by suppressing PTEN","volume":"36","author":"Wang","year":"2015","journal-title":"Cell Physiol Biochem"},{"issue":"11","key":"10.1016\/j.esmoop.2023.101573_bib78","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.2337\/db16-0166","article-title":"MicroRNA-451 negatively regulates hepatic glucose production and glucose homeostasis by targeting glycerol kinase-mediated gluconeogenesis","volume":"65","author":"Zhuo","year":"2016","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.esmoop.2023.101573_bib79","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12964-019-0394-7","article-title":"miR-449a regulates insulin signalling by targeting the Notch ligand, Jag1 in skeletal muscle cells","volume":"17","author":"Poddar","year":"2019","journal-title":"Cell Commun Signal"},{"issue":"4","key":"10.1016\/j.esmoop.2023.101573_bib80","first-page":"3639","article-title":"Reduced expression of microRNA-199a-3p is associated with vascular endothelial cell injury induced by type 2 diabetes mellitus","volume":"16","author":"Wang","year":"2018","journal-title":"Exp Ther Med"},{"issue":"3","key":"10.1016\/j.esmoop.2023.101573_bib81","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.stem.2008.01.016","article-title":"MicroRNA regulation of cell lineages in mouse and human embryonic stem cells","volume":"2","author":"Ivey","year":"2008","journal-title":"Cell Stem Cell"},{"issue":"2","key":"10.1016\/j.esmoop.2023.101573_bib82","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.bbrc.2009.08.136","article-title":"MicroRNA-133 regulates the expression of GLUT4 by targeting KLF15 and is involved in metabolic control in cardiac myocytes","volume":"389","author":"Horie","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"10.1016\/j.esmoop.2023.101573_bib83","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1159\/000445565","article-title":"Regulation of insulin resistance by multiple MiRNAs via targeting the GLUT4 signalling pathway","volume":"38","author":"Zhou","year":"2016","journal-title":"Cell Physiol Biochem"},{"issue":"4","key":"10.1016\/j.esmoop.2023.101573_bib84","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3892\/ijmm.2016.2499","article-title":"MicroRNA-29a induces insulin resistance by targeting PPAR\u03b4 in skeletal muscle cells","volume":"37","author":"Zhou","year":"2016","journal-title":"Int J Mol Med"},{"issue":"5","key":"10.1016\/j.esmoop.2023.101573_bib85","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155108","article-title":"MicroRNA-194 modulates glucose metabolism and its skeletal muscle expression is reduced in diabetes","volume":"11","author":"Latouche","year":"2016","journal-title":"PLoS One"},{"issue":"50","key":"10.1016\/j.esmoop.2023.101573_bib86","doi-asserted-by":"crossref","first-page":"52361","DOI":"10.1074\/jbc.C400438200","article-title":"MicroRNA-143 regulates adipocyte differentiation","volume":"279","author":"Esau","year":"2004","journal-title":"J\u00a0Biol Chem"},{"issue":"9","key":"10.1016\/j.esmoop.2023.101573_bib87","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1055\/s-0032-1311644","article-title":"MiRNA-21 reverses high glucose and high insulin induced insulin resistance in 3T3-L1 adipocytes through targeting phosphatase and tensin homologue","volume":"120","author":"Ling","year":"2012","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"3","key":"10.1016\/j.esmoop.2023.101573_bib88","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/cvr\/cvq010","article-title":"MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism","volume":"86","author":"Lu","year":"2010","journal-title":"Cardiovasc Res"},{"issue":"4","key":"10.1016\/j.esmoop.2023.101573_bib89","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1002\/jcp.27206","article-title":"miR-200a-5p augments cardiomyocyte hypertrophy induced by glucose metabolism disorder via the regulation of selenoproteins","volume":"234","author":"Yang","year":"2019","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.esmoop.2023.101573_bib90","article-title":"MicroRNA-223 expression is upregulated in insulin resistant human adipose tissue","volume":"2015","author":"Chuang","year":"2015","journal-title":"J\u00a0Diabetes Res"},{"key":"10.1016\/j.esmoop.2023.101573_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-6524-3_1","article-title":"MiRNA biogenesis and regulation of diseases: an overview","volume":"1509","author":"Vishnoi","year":"2017","journal-title":"Methods Mol Biol"},{"issue":"9","key":"10.1016\/j.esmoop.2023.101573_bib92","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1073\/pnas.0307323101","article-title":"Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers","volume":"101","author":"Calin","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.esmoop.2023.101573_bib93","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00335-005-0066-3","article-title":"Mammalian microRNAs: a small world for fine-tuning gene expression","volume":"17","author":"Sevignani","year":"2006","journal-title":"Mamm Genome"},{"issue":"3","key":"10.1016\/j.esmoop.2023.101573_bib94","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3390\/biomedicines9030325","article-title":"MiR-7 in cancer development","volume":"9","author":"Kora\u0107","year":"2021","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.esmoop.2023.101573_bib95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ph14020149","article-title":"The role of miRNA-7 in the biology of cancer and modulation of drug resistance","volume":"14","author":"Gajda","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"issue":"9","key":"10.1016\/j.esmoop.2023.101573_bib96","doi-asserted-by":"crossref","first-page":"14651","DOI":"10.1002\/jcp.28210","article-title":"miR-9: from function to therapeutic potential in cancer","volume":"234","author":"Khafaei","year":"2019","journal-title":"J\u00a0Cell Physiol"},{"issue":"29","key":"10.1016\/j.esmoop.2023.101573_bib97","doi-asserted-by":"crossref","first-page":"20838","DOI":"10.18632\/oncotarget.24889","article-title":"The versatile nature of miR-9\/9\u2217 in human cancer","volume":"9","author":"Nowek","year":"2018","journal-title":"Oncotarget"},{"issue":"17","key":"10.1016\/j.esmoop.2023.101573_bib98","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.2174\/1871520621666210217094839","article-title":"Emerging molecular functions of microRNA-9: cancer pathology and therapeutic implications","volume":"21","author":"Tapeh","year":"2021","journal-title":"Anticancer Agents Med Chem"},{"issue":"2","key":"10.1016\/j.esmoop.2023.101573_bib99","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/cdd.2009.69","article-title":"miR-15a and miR-16-1 in cancer: discovery, function and future perspectives","volume":"17","author":"Aqeilan","year":"2010","journal-title":"Cell Death Differ"},{"issue":"16","key":"10.1016\/j.esmoop.2023.101573_bib100","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.2217\/fon.15.101","article-title":"miRNA-15a\/16: as tumor suppressors and more","volume":"11","author":"Huang","year":"2015","journal-title":"Future Oncol"},{"issue":"24","key":"10.1016\/j.esmoop.2023.101573_bib101","doi-asserted-by":"crossref","first-page":"15524","DOI":"10.1073\/pnas.242606799","article-title":"Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia","volume":"99","author":"Calin","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.esmoop.2023.101573_bib102","first-page":"64","article-title":"Insights into regulation of the miR-17-92 cluster of miRNAs in cancer","volume":"2","author":"Fuziwara","year":"2015","journal-title":"Front Med (Lausanne)"},{"issue":"7","key":"10.1016\/j.esmoop.2023.101573_bib103","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0092-8674(03)01018-3","article-title":"Prediction of mammalian microRNA targets","volume":"115","author":"Lewis","year":"2003","journal-title":"Cell"},{"issue":"21","key":"10.1016\/j.esmoop.2023.101573_bib104","doi-asserted-by":"crossref","first-page":"9628","DOI":"10.1158\/0008-5472.CAN-05-2352","article-title":"A\u00a0polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation","volume":"65","author":"Hayashita","year":"2005","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.esmoop.2023.101573_bib105","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.biocel.2010.03.004","article-title":"mir-17-92, a cluster of miRNAs in the midst of the cancer network","volume":"42","author":"Olive","year":"2010","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.esmoop.2023.101573_bib106","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.omtn.2020.03.003","article-title":"The promising role of miR-21 as a cancer biomarker and its importance in RNA-based therapeutics","volume":"20","author":"Bautista-S\u00e1nchez","year":"2020","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.esmoop.2023.101573_bib107","article-title":"MicroRNA-24 in cancer: a double side medal with opposite properties","volume":"10","author":"Wang","year":"2020","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.esmoop.2023.101573_bib108","first-page":"20","article-title":"Versatile role of miR-24\/24-1\u2217\/24-2\u2217 expression in cancer and other human diseases","volume":"14","author":"Mukherjee","year":"2022","journal-title":"Am J Transl Res"},{"issue":"2","key":"10.1016\/j.esmoop.2023.101573_bib109","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2174\/2211536605666160905093429","article-title":"The roles of miR-25 and its targeted genes in development of human cancer","volume":"5","author":"Caiazza","year":"2016","journal-title":"MicroRNA"},{"key":"10.1016\/j.esmoop.2023.101573_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.103124","article-title":"miR-26 family and its target genes in tumorigenesis and development","volume":"157","author":"Li","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"issue":"12","key":"10.1016\/j.esmoop.2023.101573_bib111","first-page":"2518","article-title":"MiR-26b regulates 5-FU-resistance in human colorectal cancer via down-regulation of Pgp","volume":"8","author":"Wang","year":"2018","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.esmoop.2023.101573_bib112","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3389\/fonc.2019.00893","article-title":"MicroRNA-27a (miR-27a) in solid tumors: a review based on mechanisms and clinical observations","volume":"9","author":"Zhang","year":"2019","journal-title":"Front Oncol"},{"issue":"11","key":"10.1016\/j.esmoop.2023.101573_bib113","doi-asserted-by":"crossref","first-page":"19280","DOI":"10.1002\/jcp.28607","article-title":"The potential role of miR-29 in health and cancer diagnosis, prognosis, and therapy","volume":"234","author":"Alizadeh","year":"2019","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.esmoop.2023.101573_bib114","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.omto.2018.12.011","article-title":"A\u00a0systematic review of miR-29 in cancer","volume":"12","author":"Kwon","year":"2018","journal-title":"Mol Ther Oncolytics"},{"issue":"1","key":"10.1016\/j.esmoop.2023.101573_bib115","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13046-019-1059-5","article-title":"MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer","volume":"38","author":"Zhang","year":"2019","journal-title":"J\u00a0Exp Clin Cancer Res"},{"issue":"7","key":"10.1016\/j.esmoop.2023.101573_bib116","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132767","article-title":"miR-34 and p53: new insights into a complex functional relationship","volume":"10","author":"Navarro","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.esmoop.2023.101573_bib117","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1074\/jbc.M111.280768","article-title":"MicroRNA 34c gene down-regulation via DNA methylation promotes self-renewal and epithelial-mesenchymal transition in breast tumor-initiating cells","volume":"287","author":"Yu","year":"2012","journal-title":"J\u00a0Biol Chem"},{"issue":"36","key":"10.1016\/j.esmoop.2023.101573_bib118","doi-asserted-by":"crossref","first-page":"13421","DOI":"10.1073\/pnas.0801613105","article-title":"miR-34a repression of SIRT1 regulates apoptosis","volume":"105","author":"Yamakuchi","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.esmoop.2023.101573_bib119","first-page":"3","article-title":"MicroRNA-96: a therapeutic and diagnostic tumor marker","volume":"25","author":"Rahimi","year":"2022","journal-title":"Iran J Basic Med Sci"},{"issue":"4","key":"10.1016\/j.esmoop.2023.101573_bib120","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.gendis.2021.02.002","article-title":"miR-106b as an emerging therapeutic target in cancer","volume":"9","author":"Sagar","year":"2021","journal-title":"Genes Dis"},{"key":"10.1016\/j.esmoop.2023.101573_bib121","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2147\/CMAR.S232388","article-title":"The emerging roles of miR-125b in cancers","volume":"12","author":"Wang","year":"2020","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.esmoop.2023.101573_bib122","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.canlet.2019.04.015","article-title":"MicroRNA-125 in immunity and cancer","volume":"454","author":"Wang","year":"2019","journal-title":"Cancer Lett"},{"key":"10.1016\/j.esmoop.2023.101573_bib123","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1100\/tsw.2010.198","article-title":"miR-126 and miR-126\u2217: new players in cancer","volume":"10","author":"Meister","year":"2010","journal-title":"ScientificWorldJournal"},{"issue":"1","key":"10.1016\/j.esmoop.2023.101573_bib124","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.yexmp.2013.12.004","article-title":"miR-126 in human cancers: clinical roles and current perspectives","volume":"96","author":"Ebrahimi","year":"2014","journal-title":"Exp Mol Pathol"},{"issue":"4","key":"10.1016\/j.esmoop.2023.101573_bib125","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s13577-021-00544-w","article-title":"The outstanding role of miR-132-3p in carcinogenesis of solid tumors","volume":"34","author":"Rafat","year":"2021","journal-title":"Hum Cell"},{"key":"10.1016\/j.esmoop.2023.101573_bib126","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.973585","article-title":"A\u00a0review on the importance of miRNA-135 in human diseases","volume":"13","author":"Kadkhoda","year":"2022","journal-title":"Front Genet"},{"issue":"22","key":"10.1016\/j.esmoop.2023.101573_bib127","first-page":"6716","article-title":"MicroRNA-144: a novel biological marker and potential therapeutic target in human solid cancers","volume":"11","author":"Zhou","year":"2020","journal-title":"J\u00a0Cancer"},{"issue":"7","key":"10.1016\/j.esmoop.2023.101573_bib128","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.3390\/ijms21072578","article-title":"MiR-144: a new possible therapeutic target and diagnostic\/prognostic tool in cancers","volume":"21","author":"Kooshkaki","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.esmoop.2023.101573_bib129","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1002\/eji.201747132","article-title":"The role of the miR-148\/-152 family in physiology and disease","volume":"47","author":"Friedrich","year":"2017","journal-title":"Eur J Immunol"},{"issue":"5","key":"10.1016\/j.esmoop.2023.101573_bib130","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s12032-022-01653-8","article-title":"The role of miR-153 and related upstream\/downstream pathways in cancers: from a potential biomarker to treatment of tumor resistance and a therapeutic target","volume":"39","author":"Alamdari-Palangi","year":"2022","journal-title":"Med Oncol"},{"key":"10.1016\/j.esmoop.2023.101573_bib131","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.985897","article-title":"A\u00a0comprehensive review on miR-153: mechanistic and controversial roles of miR-153 in tumorigenicity of cancer cells","volume":"12","author":"Yousefnia","year":"2022","journal-title":"Front Oncol"},{"issue":"6","key":"10.1016\/j.esmoop.2023.101573_bib132","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.3390\/ijms21062092","article-title":"The pervasive role of the miR-181 family in development, neurodegeneration, and cancer","volume":"21","author":"Indrieri","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"23","key":"10.1016\/j.esmoop.2023.101573_bib133","doi-asserted-by":"crossref","first-page":"5874","DOI":"10.3390\/cancers13235874","article-title":"The miR-200 family of microRNAs: fine tuners of epithelial-mesenchymal transition and circulating cancer biomarkers","volume":"13","author":"Cavallari","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.esmoop.2023.101573_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110037","article-title":"The function of miR-200 family in oxidative stress response evoked in cancer chemotherapy and radiotherapy","volume":"125","author":"Kozak","year":"2020","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"10.1016\/j.esmoop.2023.101573_bib135","doi-asserted-by":"crossref","first-page":"11667","DOI":"10.1007\/s13277-016-5144-5","article-title":"The dual regulatory role of miR-204 in cancer","volume":"37","author":"Li","year":"2016","journal-title":"Tumour Biol"},{"issue":"4","key":"10.1016\/j.esmoop.2023.101573_bib136","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1111\/jcmm.14966","article-title":"The functions and targets of miR-212 as a potential biomarker of cancer diagnosis and therapy","volume":"24","author":"Chen","year":"2020","journal-title":"J\u00a0Cell Mol Med"},{"issue":"9","key":"10.1016\/j.esmoop.2023.101573_bib137","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.3390\/cells9091957","article-title":"miR-205: a potential biomedicine for cancer therapy","volume":"9","author":"Chauhan","year":"2020","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.esmoop.2023.101573_bib138","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/s41419-020-03192-4","article-title":"Unveiling the ups and downs of miR-205 in physiology and cancer: transcriptional and post-transcriptional mechanisms","volume":"11","author":"Ferrari","year":"2020","journal-title":"Cell Death Dis"},{"issue":"6","key":"10.1016\/j.esmoop.2023.101573_bib139","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3390\/biomedicines9060591","article-title":"MicroRNA 320, an anti-oncogene target miRNA for cancer therapy","volume":"9","author":"Liang","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.esmoop.2023.101573_bib140","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.2147\/OTT.S305098","article-title":"Functions and targets of miR-335 in cancer","volume":"14","author":"Ye","year":"2021","journal-title":"Onco Targets Ther"},{"issue":"9","key":"10.1016\/j.esmoop.2023.101573_bib141","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20211494","article-title":"MicroRNA-375: potential cancer suppressor and therapeutic drug","volume":"41","author":"Wei","year":"2021","journal-title":"Biosci Rep"},{"issue":"5","key":"10.1016\/j.esmoop.2023.101573_bib142","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/ijc.28563","article-title":"The emerging role of miR-375 in cancer","volume":"135","author":"Yan","year":"2014","journal-title":"Int J Cancer"},{"issue":"10","key":"10.1016\/j.esmoop.2023.101573_bib143","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/CAD.0000000000000555","article-title":"miR-449a: a potential therapeutic agent for cancer","volume":"28","author":"Yong-Ming","year":"2017","journal-title":"Anticancer Drugs"},{"issue":"11","key":"10.1016\/j.esmoop.2023.101573_bib144","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23989","article-title":"Dysfunction of miR-802 in tumors","volume":"35","author":"Gao","year":"2021","journal-title":"J\u00a0Clin Lab Anal"},{"issue":"5","key":"10.1016\/j.esmoop.2023.101573_bib145","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3109\/10799893.2014.896383","article-title":"Role of miR-107 and its signaling pathways in diseases","volume":"34","author":"Jiang","year":"2014","journal-title":"J\u00a0Recept Signal Transduct Res"},{"issue":"9","key":"10.1016\/j.esmoop.2023.101573_bib146","first-page":"4873","article-title":"Role and mechanism of miR-187 in human cancer","volume":"12","author":"Peng","year":"2020","journal-title":"Am J Transl Res"},{"issue":"6","key":"10.1016\/j.esmoop.2023.101573_bib147","doi-asserted-by":"crossref","first-page":"e1659","DOI":"10.1002\/wrna.1659","article-title":"The many facets of miR-223 in cancer: oncosuppressor, oncogenic driver, therapeutic target, and biomarker of response","volume":"12","author":"Favero","year":"2021","journal-title":"Wiley Interdiscip Rev RNA"},{"issue":"1","key":"10.1016\/j.esmoop.2023.101573_bib148","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s11658-021-00257-w","article-title":"Molecular interactions of miR-338 during tumor progression and metastasis","volume":"26","author":"Moghbeli","year":"2021","journal-title":"Cell Mol Biol Lett"},{"issue":"1","key":"10.1016\/j.esmoop.2023.101573_bib149","first-page":"313","article-title":"A\u00a0concise review of microRNA-383: exploring the insights of its function in tumorigenesis","volume":"13","author":"Yi","year":"2022","journal-title":"J\u00a0Cancer"},{"key":"10.1016\/j.esmoop.2023.101573_bib150","doi-asserted-by":"crossref","first-page":"11069","DOI":"10.2147\/OTT.S230963","article-title":"miR-451: a novel biomarker and potential therapeutic target for cancer","volume":"12","author":"Bai","year":"2019","journal-title":"Onco Targets Ther"},{"issue":"8","key":"10.1016\/j.esmoop.2023.101573_bib151","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042390","article-title":"miRSystem: an integrated system for characterizing enriched functions and pathways of microRNA targets","volume":"7","author":"Lu","year":"2012","journal-title":"PLoS One"},{"issue":"24","key":"10.1016\/j.esmoop.2023.101573_bib152","doi-asserted-by":"crossref","first-page":"6249","DOI":"10.3390\/ijms20246249","article-title":"Deciphering miRNAs\u2019 action through miRNA editing","volume":"20","author":"de Sousa","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.esmoop.2023.101573_bib153","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3390\/cells9010137","article-title":"RNA-based therapeutics: from antisense oligonucleotides to miRNAs","volume":"9","author":"Bajan","year":"2020","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.esmoop.2023.101573_bib154","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nrd4140","article-title":"MicroRNAs and other non-coding RNAs as targets for anticancer drug development","volume":"12","author":"Ling","year":"2013","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"10.1016\/j.esmoop.2023.101573_bib155","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jconrel.2013.09.015","article-title":"Progress in microRNA delivery","volume":"172","author":"Zhang","year":"2013","journal-title":"J\u00a0Control Release"},{"issue":"2","key":"10.1016\/j.esmoop.2023.101573_bib156","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3390\/cells9020276","article-title":"miRNAs as biomarkers in disease: latest findings regarding their role in diagnosis and prognosis","volume":"9","author":"Condrat","year":"2020","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.esmoop.2023.101573_bib157","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/s41416-020-0802-1","article-title":"Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours","volume":"122","author":"Hong","year":"2020","journal-title":"Br J Cancer"},{"issue":"14","key":"10.1016\/j.esmoop.2023.101573_bib158","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.7150\/ijbs.47203","article-title":"miRNA-based biomarkers, therapies, and resistance in cancer","volume":"16","author":"He","year":"2020","journal-title":"Int J Biol Sci"},{"issue":"14","key":"10.1016\/j.esmoop.2023.101573_bib159","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21145039","article-title":"Combinatory treatment with miR-7-5p and drug-loaded cubosomes effectively impairs cancer cells","volume":"21","author":"Gajda","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10.1016\/j.esmoop.2023.101573_bib160","doi-asserted-by":"crossref","first-page":"7821","DOI":"10.1021\/acsami.7b19183","article-title":"Enhanced chemotherapeutic efficacy of paclitaxel nanoparticles co-delivered with microRNA-7 by inhibiting paclitaxel-induced EGFR\/ERK pathway activation for ovarian cancer therapy","volume":"10","author":"Cui","year":"2018","journal-title":"ACS Appl Mater Interfaces"},{"issue":"23","key":"10.1016\/j.esmoop.2023.101573_bib161","doi-asserted-by":"crossref","first-page":"7068","DOI":"10.1158\/0008-5472.CAN-13-0927","article-title":"Silencing of the miR-17\u223c92 cluster family inhibits medulloblastoma progression","volume":"73","author":"Murphy","year":"2013","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.esmoop.2023.101573_bib162","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1158\/1541-7786.MCR-10-0363","article-title":"GT-094, a NO-NSAID, inhibits colon cancer cell growth by activation of a reactive oxygen species-microRNA-27a: ZBTB10-specificity protein pathway","volume":"9","author":"Pathi","year":"2011","journal-title":"Mol Cancer Res"},{"issue":"5","key":"10.1016\/j.esmoop.2023.101573_bib163","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1158\/1940-6207.CAPR-14-0354","article-title":"Novel evidence for curcumin and boswellic acid-induced chemoprevention through regulation of miR-34a and miR-27a in colorectal cancer","volume":"8","author":"Toden","year":"2015","journal-title":"Cancer Prev Res (Phila)"},{"issue":"4","key":"10.1016\/j.esmoop.2023.101573_bib164","first-page":"5202","article-title":"Liraglutide inhibits the proliferation and promotes the apoptosis of MCF-7 human breast cancer cells through downregulation of microRNA-27a expression","volume":"17","author":"Zhao","year":"2018","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.esmoop.2023.101573_bib165","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.biopha.2018.10.148","article-title":"Up-regulation of miR-383-5p suppresses proliferation and enhances chemosensitivity in ovarian cancer cells by targeting TRIM27","volume":"109","author":"Jiang","year":"2019","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"10.1016\/j.esmoop.2023.101573_bib166","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2337\/db21-0077","article-title":"Human islet microRNA-200c is elevated in type 2 diabetes and targets the transcription factor ETV5 to reduce insulin secretion","volume":"71","author":"Ofori","year":"2022","journal-title":"Diabetes"},{"key":"10.1016\/j.esmoop.2023.101573_bib167","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2147\/OTT.S59364","article-title":"miR-7 inhibits colorectal cancer cell proliferation and induces apoptosis by targeting XRCC2","volume":"7","author":"Xu","year":"2014","journal-title":"Onco Targets Ther"},{"issue":"7043","key":"10.1016\/j.esmoop.2023.101573_bib168","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nature03677","article-title":"c-Myc-regulated microRNAs modulate E2F1 expression","volume":"435","author":"O\u2019Donnell","year":"2005","journal-title":"Nature"},{"issue":"25","key":"10.1016\/j.esmoop.2023.101573_bib169","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1038\/onc.2012.318","article-title":"MicroRNA-125b promotes apoptosis by regulating the expression of Mcl-1, Bcl-w and IL-6R","volume":"32","author":"Gong","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.esmoop.2023.101573_bib170","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.diabres.2017.06.005","article-title":"Increased serum miR-7 is a promising biomarker for type 2 diabetes mellitus and its microvascular complications","volume":"130","author":"Wan","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"10.1016\/j.esmoop.2023.101573_bib171","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24380","article-title":"Circulating microRNAs as predictive biomarkers of coronary artery diseases in type 2 diabetes patients","volume":"36","author":"Mahjoob","year":"2022","journal-title":"J\u00a0Clin Lab Anal"},{"issue":"6","key":"10.1016\/j.esmoop.2023.101573_bib172","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1161\/CIRCRESAHA.110.226357","article-title":"Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes","volume":"107","author":"Zampetaki","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.esmoop.2023.101573_bib173","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.trsl.2022.03.008","article-title":"Circulating microRNAs as clinically useful biomarkers for type 2 diabetes mellitus: miRNomics from bench to bedside","volume":"247","author":"Grieco","year":"2022","journal-title":"Transl Res"},{"issue":"6","key":"10.1016\/j.esmoop.2023.101573_bib174","first-page":"251","article-title":"Diagnostic value of cell-free circulating microRNAs for obesity and type 2 diabetes: a meta-analysis","volume":"6","author":"Villard","year":"2015","journal-title":"J\u00a0Mol Biomark Diagn"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702923008049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702923008049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:30:40Z","timestamp":1761856240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2059702923008049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":173,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S2059702923008049"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2023.101573","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MiRNA dysregulation underlying common pathways in type 2 diabetes and cancer development: an Italian Association of Medical Oncology (AIOM)\/Italian Association of Medical Diabetologists (AMD)\/Italian Society of Diabetology (SID)\/Italian Society of Endocrinology (SIE)\/Italian Society of Pharmacology (SIF) multidisciplinary critical view","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2023.101573","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101573"}}